Cargando…

Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19

SARS-CoV-2 infection has spread uncontrollably worldwide while it remains unknown how vulnerable populations, such as Down syndrome (DS) individuals are affected by the COVID-19 pandemic. Individuals with DS have more risk of infections with respiratory complications and present signs of auto-inflam...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Toma, Ilario, Dierssen, Mara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820501/ https://www.ncbi.nlm.nih.gov/pubmed/33479353 http://dx.doi.org/10.1038/s41598-021-81451-w

Ejemplares similares

Meta-analysis of transcriptomic data reveals clusters of consistently deregulated gene and disease ontologies in Down syndrome
por: De Toma, Ilario, et al.
Publicado: (2021)

Social Factors Influence Behavior in the Novel Object Recognition Task in a Mouse Model of Down Syndrome
por: Sierra, Cesar, et al.
Publicado: (2021)

Proteomic profiling reveals mitochondrial dysfunction in the cerebellum of transgenic mice overexpressing DYRK1A, a Down syndrome candidate gene
por: Ortega, Mireia, et al.
Publicado: (2022)

SARS-CoV-2 Infection in Patients with Down Syndrome, Congenital Heart Disease, and Pulmonary Hypertension: Is Down Syndrome a Risk Factor?
por: Krishnan, Usha S., et al.
Publicado: (2020)

Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome
por: Illouz, Tomer, et al.
Publicado: (2021)

DYRK1A Overexpression Alters Cognition and Neural-Related Proteomic Pathways in the Hippocampus That Are Rescued by Green Tea Extract and/or Environmental Enrichment
por: De Toma, Ilario, et al.
Publicado: (2019)

Atypical Inflammatory Syndrome Triggered by SARS-CoV-2 in Infants with Down Syndrome
por: Malle, Louise, et al.
Publicado: (2021)

SARS-CoV-2 vaccine humoral response in adults with Down syndrome
por: Sali, Michela, et al.
Publicado: (2022)

Specific Susceptibility to COVID-19 in Adults with Down Syndrome
por: Illouz, Tomer, et al.
Publicado: (2021)

Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome
por: Illouz, Tomer, et al.
Publicado: (2021)

Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome
por: Illouz, Tomer, et al.
Publicado: (2021)

Dyrk1A Is Dynamically Expressed on Subsets of Motor Neurons and in the Neuromuscular Junction: Possible Role in Down Syndrome
por: Arque, Gloria, et al.
Publicado: (2013)

Post-infectious inflammatory syndrome associated with SARS-CoV-2 in a paediatric patient with Down syndrome
por: Khoshnood, Mellad, et al.
Publicado: (2021)

To fight SARS-CoV-2: putting your guns down
por: Dutheil, Frédéric, et al.
Publicado: (2020)

Maternal SARS-CoV-2 Vaccination and Infant Protection Against SARS-CoV-2 During the First 6 Months of Life
por: Zerbo, Ousseny, et al.
Publicado: (2022)

Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life
por: Zerbo, Ousseny, et al.
Publicado: (2023)

Protections against the Risk of Airborne SARS-CoV-2 Infection
por: McDonald, Clement J.
Publicado: (2020)

Enhancing understanding of SARS-CoV-2 infection among individuals with Down syndrome: An integrative review
por: da Silva, Maria Vitoria Gomes, et al.
Publicado: (2023)

Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing
por: Krishnamoorthy, Pandikannan, et al.
Publicado: (2021)

Potential Pathogenicity Determinants Identified from Structural Proteomics of SARS-CoV and SARS-CoV-2
por: Prates, Erica T, et al.
Publicado: (2020)

Ratcheting down the virulence of SARS‐CoV‐2 in the COVID‐19 pandemic
por: Brufsky, Adam, et al.
Publicado: (2020)

Down‐regulation of SARS‐CoV‐2 neutralizing antibodies in vaccinated smokers
por: Zhang, Jiahui, et al.
Publicado: (2022)

Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
por: Yang, Ren, et al.
Publicado: (2020)

Mouse Adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
por: Muruato, Antonio, et al.
Publicado: (2021)

Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
por: Muruato, Antonio, et al.
Publicado: (2021)

Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions
por: Dierssen, Mara, et al.
Publicado: (2020)

Effect of a SARS-CoV-2 booster vaccine dose on the immune response of adults with Down syndrome
por: Yarci-Carrión, Ayla, et al.
Publicado: (2022)

Immune correlates of SARS-CoV-2 protection
por: Brown, Matthew
Publicado: (2020)

Protective neutralizing epitopes in SARS‐CoV‐2
por: Liu, Hejun, et al.
Publicado: (2022)

SARS-CoV-2 as a protective factor for cardiovascular mortality?
por: Dutheil, Frédéric, et al.
Publicado: (2020)

Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates
por: Zhu, Daniel Y., et al.
Publicado: (2022)

Conjunctival carriage of SARS-CoV-2 using serial sampling: risk factors and protective factors
por: Liu, Shasha, et al.
Publicado: (2021)

Lamivudine, a reverse transcriptase inhibitor, rescues cognitive deficits in a mouse model of down syndrome
por: Martinez de Lagran, Maria, et al.
Publicado: (2022)

State of the Globe: “Hansen's Disease – Down but Not Out in the SARS-CoV-2 Era”
por: Thakur, Suman, et al.
Publicado: (2020)

High vaccination coverage slows down genetic diversity of SARS-CoV-2
por: Liu, Yuqi, et al.
Publicado: (2022)

SARS-CoV-2 down-regulates ACE2 through lysosomal degradation
por: Lu, Yi, et al.
Publicado: (2022)

Protective SARS-CoV-2 Antibody Response in Children With Inflammatory Bowel Disease
por: Bosa, Luca, et al.
Publicado: (2022)

Evaluation of SARS-CoV-2 diagnostics and risk factors associated with SARS-CoV-2 infection in Zambia()
por: Tembo, John, et al.
Publicado: (2022)

Reconstructed signaling and regulatory networks identify potential drugs for SARS-CoV-2 infection
por: Ding, Jun, et al.
Publicado: (2021)

452. Ongoing Surveillance of SARS-CoV-2 for In Silico Analysis to Monitor the Performance of SARS-CoV-2 Assays in BIOFIRE® Panels
por: Horrocks, Eleanor K, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cqg7s6nd3uv77gabipniucr25v